Bibliographic Details
| Title: |
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. |
| Authors: |
Waldmann TA; Metabolism Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA. tawald@helix.nih.gov, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC |
| Source: |
Blood [Blood] 2013 Jan 17; Vol. 121 (3), pp. 476-84. Date of Electronic Publication: 2012 Dec 03. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
